Clinical Trials Logo

Clinical Trial Summary

The prospective study will focus on the collection of biometric and psychometric data from a limited population for 1 month with the aim of complementing the SENSING-AI retrospective cohort.


Clinical Trial Description

The stratification of the risk of complications related to persistent COVID symptoms both physiological and psychological in a personalized way would optimize the cost-effectiveness model for the management of these patients. Similarly, the early detection of complications associated with persistent COVID in patients belonging to vulnerable groups would improve care times and, therefore, the patient's prognosis. The primary objective of this study is to complement the SENSING-AI cohort with biometric and psychometric data prospectively gathered from patients diagnosed with long COVID in the last year to drive the generation of AI-based risk prediction and stratification models. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05204615
Study type Observational
Source Adhera Health, Inc.
Contact Francisco J Núñez-Benjumea, MSc
Phone 0034 615 133 481
Email [email protected]
Status Recruiting
Phase
Start date January 18, 2022
Completion date March 2022